Daily Management Review

AstraZeneca’s Durvalumab Treatment Receives Fast-Track Approval


02/18/2016


The most of promising cancer drug developed by AstraZeneca, will speed up its research under FDA’s guidance.



AstraZeneca’s “most promising” drugs for cancer treatment have just acquired an approval from the “fast-track US regulatory” whereby it can proceed with “a particular application” of this drug.
 
A very “innovative immuno-oncology treatment”, called Durvalumab, strengthens the immune systems of the patients so as to empower the same for attacking the carcinogenic cells. The said treatment has received the “Breakthrough Therapy designation”, in short BTD, by the FDA or the “Food and Drug Administration” of the United States. It has been tested for “metastatic urothelial bladder cancer” which is inoperable.
 
According to the forecasts of the “current consensus”, all applicants indicate towards Durvalumab, which is expected to generate revenue worth “over $1.5bn” by the year of 2020.
 
Early clinical results are being encouraged through the BTD whereby treatment can be considered for serious conditions. Moreover, the FDA will be more involved and guide AstraZeneca with its ongoing research, besides providing feedback during the process of “clinical development”. Consequently, the regulatory process for the said drug is expected to speed up. The Global Head of Immuno-oncology at “AstraZeneca”, Robert Iannone said:
"Metastatic bladder cancer is an area of enormous unmet medical need. We are encouraged by this Breakthrough Therapy designation. We look forward to working closely with the FDA to bring durvalumab to bladder cancer patients as soon as possible."







References:
http://www.digitallook.com/
 







Science & Technology

Fast Company: Apple isn't the most innovative anymore

U.S. Space Program Could Be Delayed Due To SpaceX, Boeing Design Risks: Reuters

What trends will be affecting the health sector in the coming years?

Deloitte identifies main cyber threats for power industry

Zenuity To Take Self Driving Car Road Test In Sweden With Permission

Researchers: Half of Facebook users is fake

Amazon’s Ring gets in a privacy scandal

Facebook Is Creating A Stablecoin For Its WhatsApp Users

IBM offers to use the first quantum computer

Passport Numbers Of 5 Million Customers Hacked: Concedes Marriott

World Politics

World & Politics

AirHelp expects up to 33 th of cancellations and flight delays per day all over the world in 2019

Far-right and Catalonia: New elections in Spain

Trump is losing rating because of shutdown

Hanoi, Vietnam Chosen As Place For 2nd Summit Between Trump And Kim Jong-Un

US, China to hold new negotiations in Beijing

Human Rights Not To Be Dissociated From Stability, Macron Tells Sisi

Brexit Hijack Is Not The Parliament’s Right

Macedonia ignites political crisis in Greece